Oscillo Biosciences, a biotech company, aims to preserve and restore memory and cognition in people with Alzheimer’s disease and dementias.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 29, 2020 | Grant | $224.84K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |